PharmiWeb.com - Global Pharma News & Resources
23-Apr-2019

Bioanalytical Testing Services Market is Projected to Jump USD 4.57 Billion by 2026

Acumen Research and Consulting has announced the addition of the Bioanalytical Testing Services Market (By Molecule Type: Large Molecule [Immunoassays, LC-MS Studies,Others], Small Molecule; By Test Type: ADME [In-Vitro, In-Vivo], PD, PK, Bioequivalence, Bioavailability, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026 report to their offering.

The global Bioanalytical Testing Services market size is estimated to grow at CAGR above 7% over the forecast time frame 2019-2026 and reach the market value around USD 4.57 billion by 2026.

The forecast period is projected to record a CAGR of around 7%. Compared with an in-house study, the economic efficiency of outsourcing encourages the outsourcing of these services, which should boost demand. Innovation or the development of new molecules is directly proportionate to the demand for testing services. As a result of pricing problems, competitive pressures and market lead times, companies choose to outsource bioanalytical testing services. Customized care and technological developments are becoming increasingly focused on reducing the life-cycle of molecules, resulting in the fast development of new molecules.

Free Download Sample Report Pages for Better understanding at https://www.acumenresearchandconsulting.com/request-sample/1301

In the pharmaceutical analytical testing sector the performance of market players is heavily influenced by end-user demand. As awareness increases, intense market efforts, government initiatives and accessibility improvements are becoming more concerned; consumers are now more concerned about personal care which leads to higher consumption of pharmaceutical products. The increasing consumption of bioanalytical tests is projected to drive the market during the projected period.

In Shorts

Small molecules of bioanalytical test services held a lucrative share in 2018, attributed by this category of studies of bioavailability and bioequivalence (BE) to maximum generic and branded drug compounds conducted in 2019 because of their large adoption of generic medicines.

Furthermore, in 2018 the global market for bio-analytical testing services will be further stimulated by BA and BE demand for high-reliability, complex and high-end pharmaceutical products, attributed to North America's leading position on the market.

Increasing investment from many developed countries in combination with several changes to the standard of clinical trials assessment according to the global platform is expected to record the fastest CAGR over the forecast period.

Some key players are PPD, ICON Plc, Covance, LabCorp, Charles River Laboratoires International, Inc., InVentiv Health, and SGS, SA; Toxikon, Inc.; Intertek Group, LLC. Collaborations, Pace Analytical Services. Expansion of the service portfolio and combinations and acquisitions are key strategic undertakings

Regional Outlook

North America was in 2018 the world market leader in bioanalysis services. This is due to the fact that it is one of the highly reliable, complex and high-end pharmaceutical companies in the manufacturing industry. The OEMs move quickly towards electronics manufacturing service providers, so that the volume of electronic components in the current pharmaceutical products increases efficiently.

One of the main reasons for the growth of the market in North America is expected to be the rapid increase in pharmaceutical manufacture to meet increasing demand for efficient healthcare. In 2013, around 15.0% of GDP has been spent on healthcare and medical care, according to a recent study. As the government increases its support to reduce healthcare costs, the regional pharmaceutical externalization market is expected to grow further.

The most rapid growth is predicted in Asia Pacific over the forecast period as demand for outsourcing services rises in relatively unreliable markets. The delivery centers in China, Manila, and India generally support external services in this region. As a delivery location for onshore and nearshore customers from Japan, China is gaining popularity.

Major Players

The Bioanalytical Testing Services market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players of the market are Valtris Specialty Chemicals, Peter Greven GmbH amp; Co., Dover Chemical Corporation. Faci S.p. A, NoracAdditives, KG Baerlocher, GmbH. among others.

The key players are positively affected by product differentiation and expansion. Manufacturers are focused on developing surface - enhanced products. One of the main areas where manufacturers focus on production is the addition of stearic acid based on vegetable oil.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

CHAPTER 4. BIOANALYTICAL TESTING SERVICES MARKET BY TYPE

CHAPTER 5. BIOANALYTICAL TESTING SERVICES MARKET BY APPLICATION

CHAPTER 6. NORTH AMERICA BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY

CHAPTER 7. EUROPE BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY

CHAPTER 8. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY

CHAPTER 9. LATIN AMERICA BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY

CHAPTER 10. MIDDLE EAST BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY

CHAPTER 11. AFRICA BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY

CHAPTER 12. COMPANY PROFILE

CHAPTER 13. RESEARCH APPROACH

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

The report is readily available and can be dispatched immediately after payment confirmation

Buy this premium research report at https://www.acumenresearchandconsulting.com/buy-now/0/1301

Editor Details

Last Updated: 10-Jun-2019